Prescription Delivery Services Market Sales to Reach a Value of US$434.3 Million by 2029 – Full IMF Research Report

DUBAI, United Arab Emirates, March 31, 2022 (GLOBE NEWSWIRE) — Prompt delivery of medicines is the cornerstone of an efficient healthcare infrastructure. The growing prevalence of chronic and infectious diseases has accelerated the production of prescription drugs, prompting sellers to develop efficient distribution networks.

Data points Market overview
Market value 2021 US$98.7 million
Market value 2022 US$117.2 million
Market value 2030 US$434.3 million
CAGR 2022-2030 17.8%
Market share of top 5 countries 55.3%
Main market players Wal-Mart Stores, Inc., Walgreen Co., Wal-Mart Stores, Inc., CVS Health, Express Scripts Holding Company, Giant Eagle, Inc., DocMorris (Zur Rose Group AG), Rowlands Pharmacy, OptumRx, Inc., Ali Health, Kroger Co. and Amazon (PillPack)

Additionally, advanced prescription dispensing systems have not only helped in providing round-the-clock customer services, but also helped in managing dosage, treatment compliance, and providing feedback to clinicians.

Advances in consumer touchpoints and supply chains, including e-commerce, convenience stores and retail stores, have dramatically changed the landscape of prescription delivery services. Advancements such as drone delivery and tracker-based prescriptions contribute to a seamless customer experience.

Request a sample to get authentic analysis and comprehensive market insights at-

Prescription Delivery Services Market – Key Takeaways

  • Prescription drugs for diabetics will dominate and are expected to capture 36.7% market share by 2030
  • Ease of Access to Chronic Disease Medications Set to Drive Retail Pharmacy Growth to New Heights
  • North America will experience prodigious expansion at a CAGR of 18.4% from 2020 to 2030, attributed to the presence of several convenience stores and pharmacies
  • Global prescription delivery services market to reach $434.3 million by the end of 2030

“The adoption of self-service payment terminals and medicine dispensers will improve the experience of buying medicines for customers, allowing sellers to increase customer loyalty,” concludes the IMF analyst.

Information on the impact of COVID-19

The COVID-19 pandemic has generated fertile ground for the prescription dispensing services market. The imposition of nationwide shutdowns to enforce social distancing has reduced footfall at conventional pharmacies. This has forced patients to rely on online retail platforms to avail their medicines.

Learn more about analyzing reports with figures and tables of data, as well as the table of contents. Feel free to ask an analyst-

Additionally, the heightened vulnerability of geriatric people with comorbidities to coronavirus has necessitated the stockpiling of essential medicines, thus keeping the need for prescription services afloat for the duration of the pandemic. This panic buying behavior will usher in 80% year-over-year growth.

Growth should be particularly robust in the United States, China and India, countries with the highest infection rates. Collectively accounting for 40% of the global infection rate, these countries have seen an unprecedented increase in household hoarding of prescription drugs. This will continue until the second half of 2021.

Witness to the market entry of e-commerce players

The prescription delivery services market is witnessing the entry of e-commerce, pharmacies, and retail chains, albeit at the local or regional level. Technological developments, new product launches, and collaborations characterize some critical expansion strategies of market players.

Some of the major players in the prescription delivery services market are: Walgreens Co., Walmart Stores Inc., CVS Health, Giant Eagle Inc., Express Scripts Holding Company, Ali Health, and Kroger Co. to name a few- one.

Apart from these established players, several startups are also emerging as potential game changers in the industry. These include NetMeds, Kfyao, Capsule, Myra Medicines, NURX, MedAvail, Zipdrug, Insightfil and ScriptDrop to name a few.

Walgreens, a leading pharmaceutical retail distributor, has a strong presence in the global prescription delivery services market. The company offers refills, auto-refills, drug information and home delivery services.

In 2017, the company acquired Rite Aid for US$5.2 billion, merging two of the three largest drugstore chains in the United States.

Contact Sales for further assistance when purchasing this report-

Report Scope According to Prescription Delivery Services Industry Analysis

Attribute Details
Forecast period 2022-2030
Historical data available for 2015-2021
Market analysis US$ million for value
Key regions covered North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa
Main countries covered United States, Canada, Brazil, Mexico, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, South GCC, Turkey, North Africa, South Africa
Key Market Segments Covered Indication of the disease, distribution channel and region
Profiled Key Companies
  • Wal-Mart Stores, Inc.
  • Walgreen Co.
  • SVC Health
  • Express Scripts Holding Company
  • Giant Eagle, Inc.
  • DocMorris (Zur Rose Group AG)
  • Rowlands Pharmacy
  • OptumRx, Inc.
  • Ali Health
  • Kroger Co.
  • Amazon (pill)
Pricing Available on demand

Discover IMF’s extensive ongoing healthcare coverage

DNA/RNA Extraction Market: The global DNA/RNA extraction market demand is expected to grow at a CAGR of 7.7% from 2022 to 2032.

Cystatin C Testing Market: The demand for the global Cystatin C Testing Market is expected to grow at an impressive rate, growing at a significantly high CAGR throughout the forecast period 2022-2032.

Creatine Kinase Reagents Market: The global Creatine Kinase Reagents market demand is expected to grow at a CAGR of 6% from 2022 to 2032.

Immunochemistry Products Market: The immunochemistry products market is expected to register a CAGR of 7.25% during the forecast period, from US$2.08 billion in 2021 to reach a valuation of US$4.5 billion US dollars by 2032.

Hemostats for Wound Closure Market: The hemostats for wound closure market is expected to register a CAGR of 6.3% during the forecast period, from USD 2.4 billion in 2021 to reach a valuation of US$3.5 billion by 2026.

Smart Pills Technology Market: The smart pills technology market is expected to register a CAGR of 21% during the forecast period from US$627.1 million in 2020 to reach a valuation of US$6176 million. 2032.

Virology Market: The virology market is expected to register a CAGR of 5% during the forecast period, from US$2.07 billion in 2021, to reach a valuation of US$3.53 billion. here 2032.

Systemic Lupus Erythematosus (SLE) Drugs Market: Systemic Lupus Erythematosus (SLE) Drugs Market is expected to register a CAGR of 5% during the forecast period, from USD 183.3 billion in 2020, to reach a valuation of US$329.18 billion. by 2032.

Stem Cell Therapy Market: The stem cell therapy market is expected to grow at a CAGR of 16.7% to reach USD 401 million by 2026, from USD 187 million in 2021.

Breath Analyzer Market: The breath analyzer market is expected to register a CAGR of 17% during the forecast period from USD 613 million in 2021 to reach a valuation of USD 3.40 billion. 2032.

About Future Market Insights (IMF)

Future Market Insights (FMI) is a leading provider of market information and advisory services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, USA and India. FMI’s latest market research reports and industry analysis help businesses meet challenges and make critical decisions with confidence and clarity amidst fierce competition. Our custom and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of analysts led by FMI experts continuously monitor emerging trends and events across a wide range of industries to ensure our clients are prepared for the changing needs of their consumers.


future market outlook,

1602-6 Jumeirah Bay Tower X2,

Parcel number: JLT-PH2-X2A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

For sales inquiries:



main logo

Source link

About Alex S. Crone

Check Also

Analysis of the size of the non-prescription drug consumption market by 2029

This study is one of the most detailed and accurate, focusing solely on the global …